Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis of 4-boron-L-phenylalanine via halogen-magnesium exchange. Reduces 10B loss and improves yield for BNCT applications. Reliable pharma intermediate supplier.
Novel synthesis method for L-6-hydroxytryptophan derivatives offers high yield and scalable production for pharmaceutical intermediates and polypeptide drug development.
Patent CN103408573A reveals a novel NHC-catalyzed borylation method for high-purity boronic acid derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN111943967B reveals a cost-effective cobalt-catalyzed dehydroboration method yielding high-purity E-alkenyl boronates for scalable pharmaceutical manufacturing.
Patent CN108047261B reveals a high-yield route for Crisaborole using protected benzyl alcohol intermediates, offering cost-effective API manufacturing solutions.
Patent CN111217847B introduces novel thiosilane ligands for iridium-catalyzed C-H borylation, offering superior yield, easier purification, and industrial scalability for pharmaceutical intermediates.
Patent CN111217847A discloses stable thiosilane ligands for iridium-catalyzed borylation, offering superior yield and simplified purification for reliable pharmaceutical intermediate suppliers.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Patent CN116239623B reveals low-catalyst borate ester synthesis enabling high-purity pharmaceutical intermediate manufacturing with significant supply chain cost optimization.
Patent CN116751219A enables high-purity 1,3-conjugated butadiene derivatives. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN103483267B reveals a high-yield one-pot synthesis for aryl imidazole salts, enabling cost reduction in pharma intermediate manufacturing and reliable supply chain scalability.
Patent CN108299486A reveals iron catalysis for cyclopropyl boronic acid esters offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Eliminate palladium costs and impurities in crisborole intermediate production. Discover a safer, higher-yield metal-free borylation method for stable supply chains.